Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07468903
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed diagnosis of prostate adenocarcinoma within 90 days prior to registration via systematic biopsy
* Multiparametric MRI (mp-MRI) confirmed lesion(s)
* No distant or locally advanced disease on standard staging exams as indicated
* Bone scan and abdominopelvic computed tomography (CT)/MRI OR
* PSMA PET
* Eastern Cooperative Oncology Group (ECOG)/Zubrod performance status 0/1 within 60 days prior to enrollment
* Age ≥ 40
Exclusion Criteria:
* Radiographic nodal or distant metastatic disease
* Lesion(s) comprising \> 40% of total prostate volume
* Prior radiotherapy to the pelvis
* Gleason score \> 6 disease outside intended gross target volume (GTV)/target region(s)
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
40 Years
Study:
NCT07468903
Study Brief:
Protocol Section:
NCT07468903